Effects of Metformin Therapy on Anti-Mullerian Hormone (AMH) Levels in Polycystic Ovary Syndrome Patients with Insulin Resistance at Palembang
fatimah usman
2020
View PDFchevron_right
Metformin reduces serum m�llerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment
David Seifer
Fertility and Sterility, 2005
View PDFchevron_right
A Comparative Study of Clinical, Hormonal, and Metabolic Parameters and Their Response to Treatment with Metformin in Polycystic Ovarian Syndrome
Hameedah Hadi
PLANT ARCHIVES
View PDFchevron_right
Metformin Effects on Clinical Features, Endocrine and Metabolic Profiles, and Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled 6-Month Trial, followed by Open, Long-Term Clinical Evaluation1
E. Zanolin
The Journal of Clinical Endocrinology & Metabolism, 2000
View PDFchevron_right
Effects of metformin on serum insulin and anti-mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome
Lucia Alves Lara
Gynecological Endocrinology, 2013
View PDFchevron_right
Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment
Zelija Velija-Asimi
Bosnian Journal of Basic Medical Sciences, 2013
View PDFchevron_right
Effect of dose escalation of metformin on clinical features, insulin sensitivity and androgen profile in polycystic ovary syndrome
julian barth
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
View PDFchevron_right
Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome
Hannu Martikainen
Fertility and Sterility, 1998
View PDFchevron_right
Effects of metformin on polycystic ovary syndrome: a randomized, double-blind, placebo-controlled study
Md Shahed Morshed
IMC Journal of Medical Science
View PDFchevron_right
Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial
Finn Lauszus
Human Reproduction, 2007
View PDFchevron_right
Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome
E. Diamanti-kandarakis
European Journal of Endocrinology, 1998
View PDFchevron_right
Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome
Charles Glueck
Metabolism, 1999
View PDFchevron_right
The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome
Ercan Aygen
Clinical Endocrinology, 2007
View PDFchevron_right
Effect of Metformin on Hormonal and Biochemical Profile in PCOS Before and After Therapy
Sanghamitra Pati, Bratati Singh
Indian Journal of Clinical Biochemistry, 2010
View PDFchevron_right
Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo- …
Roberto Castello
Journal of Clinical …, 2000
View PDFchevron_right
Comparison of two doses of metformin (2.5 and 1.5 g/day) for the treatment of polycystic ovary syndrome and their effect on body mass index and waist circumference
Ricardo Bruno
Fertility and Sterility, 2007
View PDFchevron_right
Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance
Rainer Kimmig
European Journal of Endocrinology, 2007
View PDFchevron_right
Evaluation of metformin treatment in patient with polycystic ovary syndrome in Kirkuk city
Abdulalah T. Mohammed
Zanco Journal of Medical Sciences, 2012
View PDFchevron_right
Anti –Mullerian Hormone is a new Marker for Ovarian function in females with polycystic ovary syndrome
IOSR Journals
IOSR Journals , 2019
View PDFchevron_right
The Metformin-Induced Changes on BMI, TSH, and Thyroid Hormones Profile of Patients with Polycystic Ovarian Syndrome
Banafsheh Heidari
Reproductive System & Sexual Disorders, 2016
View PDFchevron_right
Combined use of metformin and ethinyl estradiol–cyproterone acetate in polycystic ovary syndrome
Blagovest Pehlivanov
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2005
View PDFchevron_right
Effect of Metformin Therapy Over Hormone Profile in Newly Diagnosed Polycystic Ovary Syndrome –A Nine Months Randomized Controlled Trial
Editorial Department
View PDFchevron_right
Metformin in polycystic ovary syndrome
Jonathan Lord
Annals of the New York Academy of Sciences, 2010
View PDFchevron_right
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial
Francesca Cristello
Fertility and Sterility, 2010
View PDFchevron_right
Clinicopathologic Study of Endometrial and Hormonal Changes after Metformin Therapy in Patients with Polycystic Ovary Syndrome
Tarek Emran
The Egyptian Journal of Hospital Medicine, 2018
View PDFchevron_right
Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study
Julian Barth
Human …, 2006
View PDFchevron_right